Areas of Focus
- Viral Immunology
- Histopathology
- Non-human Primate Models of Disease
Work Experience
- 2022-01~Present - Kunming Institute of Zoology, Chinese Academy of Sciences - Associate Researcher
- 2020-01~2022-01 - Kunming Institute of Zoology, Chinese Academy of Sciences - Assistant Researcher
- 2016-09~2020-01 - University of Chinese Academy of Sciences - PhD
- 2013-09~2016-06 - Sun Yat-sen University - Master's
- 2008-09~2013-07 - Shandong University of Traditional Chinese Medicine - Bachelor's
Academic Background & Achievements
- 2016-09--2020-01 PhD: University of Chinese Academy of Sciences
- 2013-09--2016-06 Master's: Sun Yat-sen University
- 2008-09--2013-07 Bachelor's: Shandong University of Traditional Chinese Medicine
Publications
- CoVac501, a self-adjuvanting peptide vaccine conjugated with TLR7 agonists, against SARS-CoV-2 induces protective immunity, Not mentioned, 2022
- Monkeypox, wild animals, and potential big problem, Not mentioned, 2022
- S-Trimer, a COVID-19 subunit vaccine candidate, induces protective immunity in nonhuman primates, Not mentioned, 2021
- Jejunal epithelial barrier disruption triggered by reactive oxygen species in early SIV infected rhesus macaques, Not mentioned, 2021
- Glucose Metabolism Disorder Induces Spermatogenic Dysfunction in Northern Pig-Tailed Macaques (Macaca leonina) With Long-Term SIVmac239 Infection, Not mentioned, 2021
- Tissue distribution of SARS-CoV-2 in non-human primates after combined intratracheal and intranasal inoculation, Not mentioned, 2021
- Northern pig-tailed macaques (Macaca leonina) infected with SARS-CoV-2 show rapid viral clearance and persistent immune response, Not mentioned, 2021
- Interferon-armed RBD dimer enhances the immunogenicity of RBD for sterilizing immunity against SARS-CoV-2, Not mentioned, 2021
- Delayed severe cytokine storm and immune cell infiltration in SARS-CoV-2-infected aged Chinese rhesus macaques, Not mentioned, 2020
Awards
- National Advanced Individual in the Fight Against COVID-19 (2021): Ministry Level
